Emily obtained her master's degree in Biomedical Sciences, with a specialisation in Clinical Epidemiology, in 2020. Thereafter, she worked for two years at the PHARMO Institute for Drug Outcomes Research as a researcher, where she was involved in the development of research protocols, data management, statistical analysis, and methodology development.
In 2022, Emily started her PhD at the Netherlands Cancer Institute and the Erasmus Medical Centre, focusing on the pre-diagnostic trajectory of newly diagnosed patients with soft tissue and bone sarcoma. Her research examines the impact of a prolonged diagnostic process on quality of life and survival within a large, international, prospective cohort study called QUEST (QUality of life and Experiences of Sarcoma Trajectories), which includes sarcoma patients from the Netherlands, the United Kingdom, Australia, and New Zealand. Alongside this, she studies the utility of real-world data in sarcoma research, working with primary care data. Additionally, she is actively involved in the EORTC Quality of Life Group, where she is working on a project related to patient involvement and collaborating on several ongoing projects. She completed a visiting fellowship at the Peter MacCallum Cancer Centre in Melbourne, and is currently pursuing psychology courses at the Open University. From September 2026, Emily will continue as a postdoctoral researcher within the team, further developing her research within the sarcoma field.